TY - JOUR AU - Weisnagel, S. John PY - 2018 TI - The role of glucagon-like peptide-1 receptor agonists in cardiovascular disease prevention in type 2 diabetes mellitus: evidence from the most recent clinical trials JF - Annals of Translational Medicine; Vol 6, No 10 (May 26, 2018): Annals of Translational Medicine (Focus on “Translational Neurodegeneration”) Y2 - 2018 KW - N2 - The field of investigation of the prevention of cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM) has seen a huge proliferation of studies on multiple drug categories and agents in the past decade. UR - https://atm.amegroups.org/article/view/18959